FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Redmile Group, LLC
2. Date of Event Requiring Statement (MM/DD/YYYY)
11/17/2020 

3. Issuer Name and Ticker or Trading Symbol

MedAvail Holdings, Inc. [MDVL]
(Last)        (First)        (Middle)

ONE LETTERMAN DRIVE, BUILDING D, SUITE D3-300
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

SAN FRANCISCO, CA 94129      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 11724726 I See Footnote (1)(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrants to Purchase Shares of Common Stock 3/4/2019 3/4/2029 Common Stock 73253 $2.09 (3)I See Footnote (1)(2)
Warrants to Purchase Shares of Common Stock 7/23/2019 7/23/2029 Common Stock 87058 $2.09 (3)I See Footnote (1)(2)
Warrants to Purchase Shares of Common Stock 12/19/2019 12/19/2029 Common Stock 54524 $1.57 I See Footnote (1)(2)
Warrants to Purchase Shares of Common Stock 5/26/2020 5/26/2030 Common Stock 74855 $1.57 I See Footnote (1)(2)
Warrants to Purchase Shares of Common Stock 10/6/2020 10/6/2030 Common Stock 15236 $1.57 I See Footnote (1)(2)

Explanation of Responses:
(1) These securities are directly owned by certain private investment vehicles and separately managed accounts managed by Redmile Group, LLC ("Redmile") and may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles and separately managed accounts. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
(2) Gerard van Hamel Platerink and Rob Faulkner, members of the board of directors of the Issuer and managing directors of Redmile, were elected to the board of the Issuer as representatives of Redmile. As a result, the Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
(3) The exercise price for the warrant is in Canadian dollars.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Redmile Group, LLC
ONE LETTERMAN DRIVE, BUILDING D
SUITE D3-300
SAN FRANCISCO, CA 94129
XX

Green Jeremy
ONE LETTERMAN DRIVE, BUILDING D
SUITE D3-300
SAN FRANCISCO, CA 94129
XX


Signatures
By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC11/27/2020
**Signature of Reporting PersonDate

/s/ Jeremy Green11/27/2020
**Signature of Reporting PersonDate

MYOS RENS Technology (NASDAQ:MYOS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more MYOS RENS Technology Charts.
MYOS RENS Technology (NASDAQ:MYOS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more MYOS RENS Technology Charts.